• Description of the dosage form
  Solution for intravenous and intramuscular administration: transparent liquid from yellow to greenish-yellow.
• Pharmacological action
  Pharmacological action – antiviral, immunomodulatory, anti-inflammatory.
  Pharmacodynamics
  CYCLOFERON® is a low-molecular interferon inducer, which determines a wide range of its biological activity (including antiviral, immunomodulatory, anti-inflammatory).
• The main cells producing interferon after the administration of CYCLOFERON® are macrophages, T- and B-lymphocytes. Depending on the type of infection, there is a predominance of activity of one or another link of the immune system. The drug induces high titers of interferon in organs and tissues containing lymphoid elements (spleen, liver, lungs), activates bone marrow stem cells, stimulating the formation of granulocytes. CYCLOFERON® activates T-lymphocytes and natural killer cells, normalizes the balance between the subpopulations of T-helpers and T-suppressors. Enhances the activity of α-suppressors and α-interferons.
• Preclinical studies have shown that the use of CYCLOFERON® in the early stages of the infectious process leads to a decrease in the viral load (virus titer) in the lung tissue. Increases non-specific resistance of the body to viral and bacterial infections.

Clinical efficacy and safety

CYCLOFERON® demonstrates antiviral activity against pathogens of tick-borne encephalitis, influenza, herpes, cytomegalovirus, papilloma virus and other viruses. High efficiency of the drug in the complex therapy of acute and chronic bacterial infections (neuroinfections, chlamydia) as a component of immunotherapy has been established.